Novartis Unveils Ambitious $23 Billion Expansion Plan to Transform U.S. Manufacturing Landscape April 11, 2025
Novartis Unveils $23 Billion Investment Plan to Transform U.S. Manufacturing and R&D Landscape April 11, 2025
Novartis Unveils $23 Billion Expansion Plan to Revolutionize U.S. Manufacturing and Drive Healthcare Innovation April 11, 2025
Crisis in Drug Development: Biotech Leaders Urge Congressional Action Amid FDA Layoffs April 10, 2025
Biden Administration’s Bold Trade Policy Shift: Tariffs on China Soar to 125% Amid Global Negotiation Push April 10, 2025
“US Temporarily Suspends Most Tariffs Amid Historic 125% Duty on Chinese Imports: A New Era in Trade Relations” April 10, 2025
Trump’s Tariff Rollback Sparks Global Trade Negotiations Amid Intensifying U.S.-China Conflict April 10, 2025
Pharmaceutical Innovations and Regulatory Milestones: A Snapshot of Recent Industry Developments April 9, 2025
